Thermo Fisher Scientific (TMO)
(Delayed Data from NYSE)
$602.02 USD
+3.99 (0.67%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $601.70 -0.32 (-0.05%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$602.02 USD
+3.99 (0.67%)
Updated Aug 6, 2024 04:00 PM ET
After-Market: $601.70 -0.32 (-0.05%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth C Momentum D VGM
Zacks News
Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Top Analyst Reports for Berkshire Hathaway, Thermo Fisher & T-Mobile
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway (BRK.B), Thermo Fisher (TMO), and T-Mobile (TMUS).
Why Thermo Fisher (TMO) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Zacks Industry Outlook Highlights: Natus Medical, IDEXX Laboratories, Hologic, Thermo Fisher Scientific and Abiomed
by Zacks Equity Research
Zacks Industry Outlook Highlights: Natus Medical, IDEXX Laboratories, Hologic, Thermo Fisher Scientific and Abiomed
3 Top Medical Instruments Stocks to Beat COVID-19 Resurgence Crisis
by Urmimala Biswas
Despite the severe challenges posed by the COVID-19 pandemic, higher demand for telemedicine, digital influence and AI is likely to lend support to the Zacks Medical - Instruments industry. NTUS, IDXX and HOLX are well positioned to gain.
Thermo Fisher (TMO) Launches Surveillance Tool for COVID-19
by Zacks Equity Research
The latest launch of surveillance solution is an extremely timely development by Thermo Fisher (TMO) and is expected to witness fast market adoption.
The Zacks Analyst Blog Highlights: Exxon Mobil, Thermo Fisher Scientific, Costco, Applied Materials and Automatic Data Processing
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Exxon Mobil, Thermo Fisher Scientific, Costco, Applied Materials and Automatic Data Processing
Top Research Reports for Exxon Mobil, Thermo Fisher & Costco
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Exxon Mobil (XOM), Thermo Fisher (TMO), and Costco (COST).
Thermo Fisher Scientific (TMO) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed at $446.87 in the latest trading session, marking a +1.23% move from the prior day.
Thermo Fisher (TMO) Down 10.9% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Thermo Fisher (TMO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Thermo Fisher (TMO) Buys Mesa Biotech, Grows in Point of Care
by Zacks Equity Research
Mesa Biotech's point-of-care platform is likely to help Thermo Fisher (TMO) rapidly scale up manufacturing volume amid the pandemic.
Thermo Fisher (TMO) Rides on Pharma & Biotech Amid Pandemic
by Zacks Equity Research
Customers in Thermo Fisher's (TMO) industrial and applied end markets get affected by business disruptions due to the pandemic.
The Zacks Analyst Blog Highlights: Microsoft, Thermo Fisher, Union Pacific, Facebook and BHP
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Microsoft, Thermo Fisher, Union Pacific, Facebook and BHP
Q4 Earnings Scorecard and Analyst Reports for Microsoft, Thermo Fisher & Union Pacific
by Sheraz Mian
Today's Research Daily features Q4 scorecard and new research reports on Microsoft (MSFT), Thermo Fisher (TMO), Union Pacific (UNP) and others.
The Zacks Analyst Blog Highlights: Comcast, Thermo Fisher, Philip Morris, Morgan Stanley and Zoom Video
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Comcast, Thermo Fisher, Philip Morris, Morgan Stanley and Zoom Video
Q4 Earnings Season Scorecard and Research Reports for Comcast, Thermo Fisher & Others
by Sheraz Mian
We have provided update on the Q4 earnings season, in addition to featuring new research reports on 16 major stocks, including Comcast (CMCSA), Thermo Fisher (TMO), and Philip Morris (PM).
Company News for Feb 2, 2021
by Zacks Equity Research
Companies in The News Are: TMO,ON,CRUS,NOC,GS
Thermo Fisher (TMO) Q4 Earnings Beat on Growth in All Segments
by Zacks Equity Research
Thermo Fisher (TMO) records $3.2 billion of COVID-19 response revenues and accelerated growth in base business in Q4.
Thermo Fisher Scientific (TMO) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Thermo Fisher (TMO) delivered earnings and revenue surprises of 3.35% and 2.67%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Thermo Fisher (TMO) Ahead of Earnings?
by Zacks Equity Research
Thermo Fisher (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
KLA-Tencor (KLAC) to Post Q2 Earnings: What's in the Cards?
by Zacks Equity Research
KLA-Tencor's (KLAC) fiscal second-quarter results are likely to reflect strong demand in Process Control systems and solid execution.
Thermo Fisher Scientific (TMO) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Thermo Fisher Scientific (TMO) closed at $518.83, marking a +0.82% move from the previous day.
Thermo Fisher (TMO) to Report Q4 Earnings: What's in Store?
by Zacks Equity Research
Thermo Fisher's (TMO) Life-Science Solutions and Specialty Diagnostics segments are expected to have contributed, banking on COVID-19-led growing healthcare needs.
Thermo Fisher (TMO) Expands in Viral Vector With Henogen Buyout
by Zacks Equity Research
The addition of Henogen's manufacturing capabilities in Europe complement Thermo Fisher's (TMO) four development and manufacturing sites in North America.
Thermo Fisher Scientific (TMO) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Thermo Fisher Scientific (TMO) closed at $503.14 in the latest trading session, marking a +1.25% move from the prior day.
The Zacks Analyst Blog Highlights: Amazon, Thermo Fisher, Eli Lilly, Google and CVS Health
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Amazon, Thermo Fisher, Eli Lilly, Google and CVS Health